Alberts DS, Martinez ME & Roe DJ (2000) The Phoenix Colon Cancer Prevention Physicians' Network. Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas. N Engl J Med 342, 1156–1162.
Ames BN & Gold LS (1990) Too many rodent carcinogens: mitogenesis increases mutagenesis. Science 249, 970–971.
Augeron C & Laboisse CL (1984) Emergence of permanently differentiated cell clones in a human colonic cancer cell line in culture after treatment with sodium butyrate. Cancer Res 44, 3961–3969.
Bartram HP, Scheppach W, Schmid H, Hofmann A, Dusel G, Richter F, Richter A & Kasper H (1993) Proliferation of human colonic mucosa as an intermediate biomarker of carcinogenesis: effects of butyrate, desoxycholate, calcium, ammonia, and pH. Cancer Res 53, 3283–3288.
Beyer-Sehlmeyer G, Glei M, Hartmann F, Hughes R, Persin C, Böhm V, Rowland IR, Schubert R, Jahreis G, Pool-Zobel BL (2003) Butyrate is only one of several growth inhibitors produced during gut flora-mediated fermentation of dietary fibre sources. Br J Nutr 90, 1057–1070.
Bingham SA, Day NE & Luen R (2003) Dietary fibre in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC): an observational study. Lancet 361, 1496–1501.
Bird RP (1987) Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett 37, 147–151.
Bolognani F, Rumney CJ, Coutts JT, Pool-Zobel BL & Rowland IR (2001) Effect of lactobacilli, bifidobacteria and inulin on the formation of aberrant crypt foci in rats. Eur J Nutr 40, 293–300.
Bonithon-Kopp C, Kronborg O & Giacosa A (2000) Calcium and fibre supplementation in prevention of colorectal adenoma recurrence: a randomised intervention trial. Lancet 356, 1300–1306.
Bouhnik Y, Vahedi K, Achour L, Attar A, Salfati J, Pochart P, Marteau P, Flourie B, Bornet F & Rambaud JC (1999) Short-chain fructo-oligosaccharide administration dose-dependently increases fecal bifidobacteria in healthy humans. J Nutr 129, 113–116.
Caderni G, Luceri C, DeFilippo C, Salvadori M, Giannini A, Tessitore L & Dolara P (2001) Slow-release pellets of sodium butyrate do not modify azoxymethane (AOM)-induced intestinal carcinogenesis in F344 rats. Carcinogenesis 22, 525–527.
Campbell JM, Fahey GC, Jr Wolf BW (1997) Selected indigestible oligosaccharides affect large bowel mass, cecal and fecal short-chain fatty acids, pH and microflora in rats. J Nutr 127, 130–136.
Compher CW, Frankel WL, Tazelaar J, Lawson JA, McKinney S, Segall S, Kinosian BP, Williams NN & Rombeau JL (1999) Wheat bran decreases aberrant crypt foci, preserves normal proliferation, and increases intraluminal butyrate levels in experimental colon cancer. J Parenter Enteral Nutr 23, 269–277.
Corpet DE & Pierre F (2003) Point: from animal models to prevention of colon cancer. Systematic review of chemoprevention in Min mice and choice of the model system. Cancer Epidemiol Biomarkers Prev 12, 391–400.
DeFilippo C, Caderni G, Bazzicalupo M, Briani C, Giannini A, Fazi M & Dolara P (1998) Mutations of the Apc gene in experimental colorectal carcinogenesis induced by azoxymethane in F344 rats. Br J Cancer 77, 2148–2151 Abstr.
Ebert MN, Beyer-Sehlmeyer G, Liegibel UM, Kautenburger T, Becker TW, Pool-Zobel BL (2001) Butyrate-induces glutathione S-transferase in human colon cells and protects from genetic damage by 4-hydroxynonenal. Nutr Cancer 41, 156–164.
Ebert MN, Klinder A, Schäferhenrich A, Peters WHM, Sendt W, Scheele J, Pool-Zobel BL (2003) Expression of glutathione S-transferases (GST) in human colon cells and inducibility of GSTM2 by butyrate. Carcinogenesis 24, 1637–1644.
Fazeli A, Steen RG, Dickinson SL, Bautista D, Dietrich WF, Bronson RT, Bresalier RS, Sander ES, Costa J & Weinberg RA (1997) Effects of p53 mutations on apoptosis in mouse intestinal and human colonic adenomas. Proc Natl Acad Sci USA 94, 10199–10204.
Fearon ER & Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 61, 759–767.
Femia AP, Luceri C, Dolara P, Giannini A, Biggeri A, Salvadori M, Clune Y, Collins KJ, Paglierani M & Caderni G (2002) Antitumourigenic activity of the prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis on azoxymethane-induced colon carcinogenesis in rats. Carcinogenesis 23, 1953–1960.
Ferguson LR (1999) Natural and man-made mutagens and carcinogens in the diet. Introduction to special issue of mutation research. Mutat Res 443, 1–10.
Ferguson LR & Harris PJ (2003) The dietary fibre debate: more food for thought – commentary. Lancet 361, 1487–1488.
Ferguson LR, Chavan RR & Harris PJ (2001) Changing concepts of dietary fiber: implications for carcinogenesis. Nutr Cancer 39, 155–169.
Fodde R, Smits R & Clevers H (2001) APC signal transduction and genetic instability in colorectal cancer. Nat Rev Cancer 1, 55–67.
Fuchs CS, Giovannucci E, Colditz GA, Hunter DJ, Stampfer MJ, Rosner B, Speizer FE & Willett WC (1999) Dietary fiber and the risk of colo-rectal cancer and adenoma in women. N Engl J Med 340, 169–176.
Gallaher DD & Khil J (1999) The effect of synbiotics on colon carcinogenesis in rats. J Nutr 129, 1483S–1487S.
Gallaher DD, Stallings WH, Blessing LL, Busta FF & Brady LJ (1996) Probiotics, cecal microflora, and aberrant crypts in the rat colon. J Nutr 126, 1362–1371.
Gibson GR & Roberfroid MB (1995) Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr 125, 1401–1412.
Gibson PR, Rosella O, Wilson AJ, Mariadason JM, Rickard K, Byron K & Barkla DH (1999) Colonic epithelial cell activation and the paradoxical effects of butyrate. Carcinogenesis 20, 539–544.
Hague A, Manning AM, Hanlon KA, Huschtscha LI, Hart D & Paraskeva C (1993) Sodium butyrate induces apoptosis in human colonic tumour cell lines in a p53-independent pathway: implications for the possible role of dietary fibre in the prevention of large-bowel cancer. Int J Cancer 55, 498–505.
Hague A, Singh B & Paraskeva C (1997) Butyrate acts as a survival factor for colonic epithelial cells: further fuel for the in vivo versus in vitro debate. Gastroenterology 112, 1036–1040.
Harris PJ & Ferguson LR (1993) Dietary fibre: its composition and role in protection against colorectal cancer. Mutat Res 290, 97–110.
Hidaka H, Eida T, Takizawa T, Tokunaga T & Tashiro Y (1986) Effects of fructooligosaccharides on intestinal flora and human health. Bifidobacteria Microflora 5, 37–50.
Hughes R & Rowland IR (2001) Stimulation of apoptosis by two prebiotic chicory fructans in the rat colon. Carcinogenesis 22, 43–47.
Jacoby RF, Cole CE, Lubet RA & You M (2001) Effect of the non-specific Cox1/2 inhibitor piroxicam and the ornithine decarboxylase inhibitor difluoromethylornitine (DFMO) on development of intestinal tumours in mice bearing germline alteration the Msh2 or APC genes. Proc Am Assoc Cancer Res 42 263 Abstr., 1422.
Johnson IT (1995) Butyrate and markers of neoplastic change in the colon. Eur J Cancer Prev 4, 365–371.
Johnson IT, Williamson G & Musk SRR (1994) Anticarcinogenic factors in plant foods: a new class of nutrients?. Nutr Res Rev 7, 175–204.
Klinder A, Förster A, Caderni G, Femia AP, Pool-Zobel BL ((2004a)) Fecal water genotoxicity is predictive of tumor-preventive activities by inulin-like oligofructoses, probiotics ( Lactobacillus rhamnosus and Bifidobacterium lactis ) and their synbiotic combination. Nutr Cancer 49, 144–155.
Klinder A, Gietl E, Hughes R ((2004b)) Gut fermentation products of inulin-derived prebiotics inhibit markers of tumour progression in human conon tumour cells. Int J Cancer Prev 1, 19–32.
Kobayashi H, Tan ME & Fleming SE (2003) Sodium butyrate inhibits cell growth and stimulates p21 wap/CIPI protein in human colonic adenocarcinoma cells independently of p53 status. Nutr Cancer 46, 202–211.
Kok TMCM, van Maanen JMS (2000) Evaluation of fecal mutagenicity and colorectal cancer risk. Mutat Res 463, 53–101.
Koo M & Rao AV (1991) Long-term effect of bifidobacteria and Neosugar on precursor lesions of colonic cancer in CF1 mice. Nutr Cancer 16, 249–257.
Kruh J (1982) Effects of sodium butyrate, a new pharmacological agent on cells in culture. Mol Cell Biochem 42, 65–82.
Levin B (2003) Potential pitfalls in the use of surrogate endpoints in colorectal adenoma chemoprevention. JNCI Cancer Spectr 95, 697.
Lipkin M (in preparation). Effects of Raftilose on tumor occurrence in APC MIN mice. Report, Orafti, Tienen, Belgium.
Lupton JR (1995) Butyrate and colonic cytokinetics: differences between in vitro and in vivo studies. Eur J Cancer Prev 4, 373–378.
Lupton JR (2004) Microbial degradation products influence colon cancer risk, the butyrate controversy. J Nutr 134, 479–482.
McIntosh GH, Royle PJ & Pointing G (2001) Wheat aleurone flour increases cecal β-glucuronidase activity and butyrate concentration and reduce colon adenoma burden in azoxymethane treated rats. J Nutr 131, 127–131.
McIntyre A, Gibson PR & Young GP (1993) Butyrate production from dietary fibre and protection against large bowel cancer in a rat model. Gut 34, 386–391.
McLellan EA & Bird RP (1988) Aberrant crypts: potential preneoplastic lesions in the murine colon. Cancer Res 48, 6187–6192.
Magnuson B, Carr I & Bird RP (1993) Ability of aberrant crypt foci characteristics to predict colonic tumour incidence in rats fed cholic acid. Cancer Res 53, 4499–4504.
Mariadason JM, Corner GA & Augenlicht LH (2000) Genetic reprogramming in pathways of colonic cell maturation induced by shortchain fatty acids; comparison with trichostatin A, sulindac and curcumin, and implications for chemoprevention of colon cancer. Cancer Res 60, 4561–4572.
Mariadason JM, Velchich A, Wilson AJ, Augenlicht LH & Gibson PR (2001) Resistance to butyrate-induced cell differentiation and apoptosis during spontaneous Caco-2 cell differentiation. Gastroenterology 120, 889–899.
Mutanen M, Pajari AM & Oikarinen SI (2000) Beef induces and rye bran prevents the formation of intestinal polyps in Apc Min mice: relation to β-catenin and PKC isozymes. Carcinogenesis 21, 1167–1173.
Oberreuther-Moschner D, Jahreis G, Rechkemmer G, Pool-Zobel BL (2004) Dietary intervention with the probiotics Lactobacillus acidophilus 145 and Bifidobacterium longum 913 modulates the potential of human faecal water to induce damage in HT29clone19A cells. Br J Nutr 91, 925–932.
Osswald K, Becker TW, Grimm M, Jahreis G, Pool-Zobel BL (2000) Inter- and intra-individual variation of faecal water – genotoxicity in human colon cells. Mutat Res 472, 59–70.
Pajari AM, Rajakangas J, Päivärinta E, Kosma VM, Rafter J & Mutanen M (2003) Promotion of intestinal tumour formation by inulin is associated with an accumulation of β-catenin in MIN mice. Int J Cancer 106, 653–660.
Pereira MA, Barnes LH, Rassman VL, Kelloff GV & Steele VE (1994) Use of azoxymethane-induced foci of aberrant crypts in rat colon to identify potential cancer chemopreventive agents. Carcinogenesis 15, 1049–1054.
Perrin P, Pierre F, Patry Y, Champ M, Berreur M, Pradal G, Bornet P, Meflah K & Menenteau J (2001) Only fibres promoting a stable butyrate producing colonic ecosystem decrease the rate of aberrant crypt foci in rats. Gut 48, 53–61.
Peters U, Sinha R & Chaterjee N (2003) Dietary fibre and colorectal adenoma in a colorectal cancer early detection programme. Lancet 361, 1401–1405.
Pierre F, Perrin P, Champ M, Bornet F, Meflah K & Menanteau J (1997) Short chain fructo-oligosaccharides reduce the occurrence of colon tumours and develop gut associated lymphoid tissue in Min mice. Cancer Res 57, 225–228.
Pietinen P, Malila N, Virtanen M, Hartman TJ, Tangrea JA, Albanes D & Virtamo J (1999) Diet and risk of colorectal cancer in a cohort of Finnish men. Cancer Causes Control 10, 387–396.
Pool-Zobel BL & Cherbut C (2003) Discussion forum on ‘diets enriched with cereal brans or inulin modulate protein kinase C activity and isozyme expression in rat colonic mucosa’ – Comments by Pool-Zobel Cherbut. Br J Nutr 89, 283–284.
Pool-Zobel BL, Neudecker C, Domizlaff I, Ji S, Schillinger U, Rumney CJ, Moretti M, Villarini M, Scassellati-Sforzolini G & Rowland IR (1996) Lactobacillus - and Bifidobacterium -mediated antigenotoxicity in colon cells of rats: prevention of carcinogen-induced damage in vivo and elucidation of involved mechanisms. Nutr Cancer 26, 365–380.
Pool-Zobel BL, Van Loo J, Rowland IR & Roberfroid MB (2002) Experimental evidences on the potential of prebiotic fructans to reduce the risk of colon cancer. Br J Nutr 87, S273–S281.
Potter JD (1999) Colorectal cancer: molecules and populations. J Natl Cancer Inst 91, 916–932.
Poulson M, Mølck AM & Jacobsen BL (2002) Different effects of short- and long-chained fructans on large intestinal physiology and carcinogen-induced aberrant crypt foci in rats. Nutr Cancer 42, 194–205.
Rafter J, Chin SM, Andersson AM, Alder R, Eng W & Bruce R (1987) Cellular toxicity of faecal water depends on diet. Am J Clin Nutr 45, 559–563.
Rao CV, Chou D, Simi B, Ku H & Reddy BS (1998) Prevention of colonic aberrant crypt foci and modulation of large bowel microbial activity by dietary coffee fiber, inulin and pectin. Carcinogenesis 19, 1815–1819.
Reddy BS, Hamid R & Rao CV (1997) Effect of dietary oligofructose and inulin on colonic preneoplastic aberrant crypt foci inhibition. Carcinogenesis 18, 1371–1374.
Roberfroid MB (1998) Prebiotics and synbiotics: concepts and nutritional properties. Br J Nutr 80, S197–S202.
Roberfroid MB, Van Loo J & Gibson GR (1998) The bifidogenic nature of chicory inulin and its hydrolysis products. J Nutr 128, 11–19.
Rowland IR (1991) Nutrition and gut flora metabolism Nutrition, Toxicity and Cancer, 113–136 [Rowland IR, editors]. Boca Raton, Ann Arbor, Boston, London: CRC Press.
Rowland IR (1993) Diet, gut microflora and carcinogenesis Food, Nutrition and Chemical Toxicity, 337–341 [Parke DVWalker R, editors]. Great Britain: Smith-Gordon.
Rowland IR, Bearne CA, Fischer R, Pool-Zobel BL (1996) The effect of lactulose on DNA damage induced by 1,2-dimethylhydrazine in the colon of human-flora-associated rats. Nutr Cancer 26, 38–47.
Rowland IR, Rumney CJ, Coutts JT & Lievense LC (1998) Effect of Bifidobacterium longum and inulin on gut bacterial metabolism and carcinogen-induced aberrant crypt foci in rats. Carcinogenesis 19, 281–285.
Schatzkin A, Lanza E & Corle D (2000) The Polyp Prevention Trial Study Group. Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas. N Engl J Med 342, 1149–1155.
Schiffman MH (1987) Diet and faecal genotoxicity. Cancer Surv 6, 653–672.
Shoemaker AR, Luongo C, Moser AR, Marton LJ & Dove WF (1997) Somatic mutational mechanisms involved in intestinal tumour formation in Min mice. Cancer Res 57, 1999–2006.
Taper HS & Roberfroid M (1999) Influence of inulin and oligofructose on breast cancer and tumour growth. J Nutr 129, 1488S–1491S.
Taper HS & Roberfroid MB (2000) Inhibitory effect of dietary inulin or oligofructose on the development of cancer metastases. Anticancer Res 20, 4291–4294.
Taper HS & Roberfroid MB (2000b) Nontoxic potentiation of cancer chemotherapy by dietary oligofructose or inulin. Nutr Cancer 38, 1–5.
Taper HS & Roberfroid MB (2002) Inulin/oligofructose and anticancer therapy. Br J Nutr 87, S283–S286.
Taper HS, Lemort C & Roberfroid MB (1998) Inhibition effect of dietary inulin and oligofructose on the growth of transplantable mouse tumour. Anticancer Res 18, 4123–4126.
Terpstra OT, van Blankenstein M, Dees J & Eilers GAM (1987) Abnormal pattern of cell proliferation in the entire colonic mucosa of patients with colon adenoma or cancer. Gastroenterology 92, 704–708.
Terry P, Giovannucci E, Michels KB, Bergvist L, Hansen H, Holmberb L & Wolk A (2001) Fruit, vegetables, dietary fiber, and risk of colorectal cancer. J Natl Cancer Inst 93, 525–533.
Thun MJ, Henley SJ & Patrono C (2002) Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. J Natl Cancer Inst 94, 252–266.
Van Loo J (1995) On the presence of inulin and oligofructose as natural ingredients in the Western diet. Crit Rev Food Sci Nutr 35, 525–552.
Venturi M, Hambly RJ, Glinghammer B, Rafter JJ & Rowland IR (1997) Genotoxic activity in human faecal water and the role of bile acids: a study using the alkaline comet assay. Carcinogenesis 18, 2353–2359.
Verghese M, Rao DR, Chawan CB & Shackelford L (2002) Dietary inulin suppresses azoxymethane-induced preneoplastic aberrant crypt foci in mature Fisher 344 rats. J Nutr 132, 2804–2808.
Verghese M, Rao DR, Chawan CB, Williams LL & Schackelford LA (2002b) Dietary inulin suppresses azoxymethane-induced aberrant crypt foci and colon tumours at the promotion stage in young Fisher 344 rats. J Nutr 132, 2809–2813.
Verghese M, Walker LT, Shackelford L, Chawan CB, Van Loo J (2003) Inhibitory effects of non-digestible carbohydrates of different chain lengths on AOM-induced aberrant crypt foci in Fisher 344 rats. In Proceedings of the Second Annual AACR International Conference 'Frontiers in Cancer Prevention Research', Phoenix, AZ, 26–30 October 2003. Poster B186 Abstr.
Wargovich MJ, Harris C, Chen CD, Palmer C, Steele VE & Kelloff GF (1992) Growth kinetics and chemoprevention of aberrant crypts in the rat colon. J Cell Biochem, Suppl. 15G, 51–54.
Wattenberg LW (1992) Inhibition of carcinogenesis by minor dietary constituents. Cancer Res 52, Suppl., 2085s–2091s.
Wollowski I, Ji S, Bakalinsky AT, Neudecker C, Pool-Zobel BL (1999) Bacteria used for the production of yogurt inactivate carcinogens and prevent DNA damage in the colon of rats. J Nutr 129, 77–82.
World Cancer Research Fund American Institute for Cancer Research (1997) Food, Nutrition and The Prevention of Cancer: A Global Perspective, Washington DC: American Institute for Cancer Research.
Yang K, Fan K, Shinozaki H, Newmark H, Edelmann W, Kucherlapati R & Lipkin M (1999) Sulindac increases carcinoma development in the colons of mice with Apc mutations. Proc Am Assoc Cancer Res 40 523 Abstr. 3488.
Yang K, Fan K, Lia M, Edelmann W, Augenlicht LH, Lubet R, Kopelovich L, Kucherlapati R & Lipkin M (2001) Sulindac increases tumour development in the colon of mice with Mlh1/mutation. Proc Am Assoc Cancer Res 42 264 Abstr. 1423.